1,830.00p-70.00 (-3.68%)05 Dec 2025, 17:27
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Bioventix PLC Fundamentals

Company NameBioventix PLCLast Updated2025-12-05
IndustryBiotechnologySectorHealthcare
Shares in Issue5.225 mMarket Cap£95.61 m
PE Ratio12.77Dividend per Share£1.57
Dividend Yield8.2Dividend Cover0.91
EPS£1.43EPS Growth (%)-0.08
PEG0DPS Growth (%)-0.0063
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio1.1136Cash Equity Ratio0.4397
Quick Ratio8.6299Current Ratio9.17
Price To Book Value8.2781ROCE0

Bioventix PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total
Prelim2025-11-062025-11-21GBP0.8000
Interim2025-04-102025-04-25GBP0.7000
Prelim2024-11-072024-11-21GBP0.8700
Interim2024-04-112024-04-26GBP0.6800
Prelim2023-11-092023-11-24GBP0.9000
Interim2023-04-062023-04-21GBP0.6200

Bioventix PLC Company Financials

Assets2025202420232022
Tangible Assets£404,357.00£477,997.00£575,726.00£694,370.00
Intangible Assets0000
Investments£426,733.00£426,733.00£610,039.00£610,039.00
Total Fixed Assets£831,090.00£904,730.00£1.19 m£1.30 m
Stocks£689,404.00£615,345.00£565,366.00£461,815.00
Debtors£6.24 m£6.21 m£5.81 m£5.22 m
Cash & Equivalents£5.08 m£6.00 m£5.72 m£6.13 m
Other Assets0000
Total Assets£12.86 m£13.73 m£13.28 m£13.12 m
Liabilities2025202420232022
Creditors within 1 year£1.31 m£1.73 m£1.20 m£1.25 m
Creditors after 1 year00£18,224.00£44,276.00
Other Liabilities0000
Total Liabilities£1.31 m£1.73 m£1.22 m£1.30 m
Net assets£11.55 m£12.00 m£12.06 m£11.82 m
Equity2025202420232022
Called up share capital£261,243.00£260,983.00£260,983.00£260,467.00
Share Premium£1.54 m£1.47 m£1.47 m£1.33 m
Profit / Loss£10.10 m£10.60 m£10.13 m£9.28 m
Other Equity£11.55 m£12.00 m£12.06 m£11.82 m
Preference & Minorities0000
Total Capital Employed£11.55 m£12.00 m£12.06 m£11.82 m
Ratios2025202420232022
Debt Ratio0000
Debt-to-Equity0000
Assets / Equity1.11361.11361.11361.1136
Cash / Equity0.43970.43970.43970.4397
EPS£1.45£1.58£1.61£1.47
Cash Flow2025202420232022
Cash from operating activities£7.03 m£8.34 m£7.80 m£7.56 m
Cashflow before financing-£1.09 m£97,079.00-£501,342.00-£361,383.00
Increase in Cash-£919,658.00£283,134.00-£410,831.00-£368,335.00
Income2025202420232022
Turnover£13.12 m£13.61 m£12.82 m£11.72 m
Cost of sales£1.20 m£925,527.00£828,410.00£710,446.00
Gross Profit£11.92 m£12.68 m£11.99 m£11.01 m
Operating Profit£9.90 m£10.58 m£10.03 m£9.27 m
Pre-Tax profit£10.10 m£10.60 m£10.13 m£9.28 m

Bioventix PLC Company Background

SectorHealthcare
ActivitiesBioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country.
Latest Interim Date31 Mar 2025
Latest Fiscal Year End Date27 Oct 2025

Bioventix PLC Directors

AppointedNamePosition
2025-11-26Mr. Bruce Edward Heath Hiscock Executive Director,Chief Financial Officer
2025-11-11Mr. Ian James NicholsonNon-Executive Director,Chairman
2025-11-11Mr. Peter John HarrisonExecutive Director,Chief Executive Officer
2020-07-01Ms. Treena Joan TurnerNon-Executive Director,Finance Director
2025-11-11Mr. Nicholas John McCookeNon-Executive Director

Bioventix PLC Contact Details

Company NameBioventix PLC
Address27-28 Eastcastle Street, London, W1W 8DH
Telephone+44 1252728001
Websitehttps://www.bioventix.com

Bioventix PLC Advisors

SolicitorCharles Russell Speechlys LLP
Phone+44 2072035000
Nominated AdviserFinnCap
Phone+44 2072200500
Fax+44 2072200597
AuditorJames Cowper Kreston
Phone+44 1189590261
StockbrokerFinnCap
Phone+44 2072200500
Fax+44 2072200597
RegistrarShare Registrars Limited
Phone+44 1252821390
Fax+44 1252719232